In recent years, a growing number of methods for p53-based therapy, such as the use of small molecules that can inhibit the interaction between p53 and its negative regulators, mouse double minute 2/4 (MDM2/4), small molecules that can reactivate the function of mutant p53, and drugs that target specific types of p53 mutants, have emerged
doi: 10.1007/s002400050166 289 Moreno-SnchezRMarn-Hernndez.Gallardo-PrezJCPacheco-VelzquezSCRobledo-CadenaDXPadilla-FloresJAet al
Ozempic: Every Celebrity Who Has Spoken About The Weight-Loss Drug Lizzo is the latest star to talk openly about the weight-loss drug
#BiohackYourself #HealthNews #PharmaSafety #DrugRecall #PublicHealth #FDAAlert #EpinephrineRecall Disclaimer: This content is for educational and entertainment purposes only, not a substitute for medical advice
The specificity of initial antibodies to GLP-1R protein was also controversial
Adipose tissue at entheses: the innervation and cell composition of the retromalleolar fat pad associated with the rat Achilles tendon
